Biotechnology Newswire
Sarah Cannon Research Institute Presents New Findings in Breast Cancer Treatment
NASHVILLE, Tenn.-(Business Wire)-September 5, 2008 - Sarah Cannon Research Institute (SCRI) investigators have found that "smart bomb" therapies are effective in treating breast cancer patients while minimizing side effects. Howard A. Burris III, M.D., SCRI's chief medical officer, is presenting...
New Partnerships for Advanced Biofuels, Biobased Products to Be Showcased at BIO's Pacific Rim Summit
WASHINGTON-(Business Wire)-September 5, 2008 - More than 400 business leaders and public officials will gather at the Pacific Rim Summit on Industrial Biotechnology and Bioenergy, Sept. 10-12 in Vancouver, British Columbia to showcase new business models and public policies for commercializing...
Orthofix International Announces Expansion of Product Offerings
BOSTON-(Business Wire)-September 5, 2008 - Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that the Company has received 510(k) approval from the FDA for its unique new PILLAR SA spine interbody device, and also received a Notification of Approval to begin selling its...
BioPharm America 2008 Presenter Profile for Debiopharm
ATLANTA-(Business Wire)-September 5, 2008 - BioPharm America 2008 takes place September 9 - 10, 2008 at the Grand Hyatt Atlanta in Buckhead. Listed below is Debiopharm's presenter profile. For in-depth information about BioPharm America 2008, visit...
A New Potential Path to Curing Inflammatory Bowel Diseases Emerges through Gene Research Funded by the Crohn's & Colitis Foundation of America
NEW YORK-(Business Wire)-September 5, 2008 - In the September 5 issue of the journal Cell, a group of researchers led by Richard Blumberg, MD, Chief of the Division of Gastroenterology, Hepatology and Endoscopy at the Brigham and Women's Hospital and Professor of Medicine at Harvard Medical...
Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims
SAN DIEGO-(Business Wire)-September 5, 2008 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and The Salk Institute for Biological Studies (SALK) have entered into a Settlement Agreement and Mutual Release of All Claims (Settlement Agreement). Through the Settlement Agreement, the parties have...
Lifeline Biotechnologies, Inc. Reorganizes Outstanding and Reduces Authorized Shares
RENO, Nev.-(Business Wire)-September 5, 2008 - Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO), a developer of innovative medical technology, today announced that it has reorganized its common stock by a reverse split of one share for each one hundred and fifty (1/150) of issued and outstanding...
Meridian Bioscience to Present at the Robert W. Baird 2008 Small Cap Healthcare Conference
CINCINNATI-(Business Wire)-September 5, 2008 - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the Robert W. Baird 2008 Small Cap Healthcare Conference on Wednesday, September 10, 2008 at 12:50 p.m. ET at the Intercontinental...
NeurAxon's NXN-188 Demonstrates Pain Relief in Migraine with Aura
WALTHAM, Mass.-(Business Wire)-September 5, 2008 - NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced data from its Phase 2 clinical trial of NXN-188 in patients with migraine. In the study, patients experiencing migraine...
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
CARLSBAD, Calif.-(Business Wire)-September 5, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the appointment of Joe Beery as head of Invitrogen's Global Information Technology, effective...
Inhibiton Therapeutics' Researcher to Present at the Ehrlich II, 2ND World Conference on "Magic Bullets"
CENTENNIAL, Colo.-(Business Wire)-September 5, 2008 - Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today that the principal researcher for its ICA-1 compound, Dr. Mildred Acevedo-Duncan, will present the work for ICA-1 entitled "PKC-i inhibition by ICA-1 reduces the cell proliferation of...
GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate
GAITHERSBURG, Md.-(Business Wire)-September 5, 2008 - GlycoMimetics, Inc., a privately held company developing a new class of glycobiology-based therapies for a broad range of indications, today announced it has initiated a Phase 1 clinical trial for GMI-1070, its lead drug candidate for the...
Phase Forward Acquires Clarix LLC, Innovation Leader in Web-Integrated Interactive Response Technology (IRT) for Clinical Trials
WALTHAM, Mass.-(Business Wire)-September 5, 2008 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, an innovative provider of fully Web-integrated interactive response...
An Essential and Comprehensive Report on Biopharmaceuticals in the US and European Markets
DUBLIN, Ireland-(Business Wire)-September 5, 2008 - Research and Markets concerning biopharmaceutical products! — Encyclopaedic monographs concentrate on products' biotechnology and commercial aspects — Includes all biopharmaceuticals - recombinant and other proteins, monoclonal...
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
CAMBRIDGE, Mass. & DUBLIN, Ireland-(Business Wire)-September 5, 2008 - Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of the first clinical trial of TYSABRI(R) (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in...
Guidance Software Shares Expertise at eDiscovery Event for Pharmaceutical, Biotech and Medical Device Industries
PASADENA, Calif.-(Business Wire)-September 4, 2008 - Guidance Software, Inc. (NASDAQ:GUID), the World Leader in Digital Investigations(TM), whose customers include many pharmaceutical and biotech companies, including Bristol-Meyers Squibb, Pfizer and Wyeth, today announced it will have a significant...
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-September 4, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 1:50 p.m. EDT and at the Morgan Stanley Global Healthcare...
InSite Vision Announces Webcast of Presentation at The Wall Street Analyst Forum's 19th Annual Institutional Investor Conference
ALAMEDA, Calif.-(Business Wire)-September 4, 2008 - InSite Vision Incorporated (AMEX:ISV) today announced that S. Kumar Chandrasekaran, Ph.D., Chairman and Chief Executive Officer, will present an overview of the company at The Wall Street Analyst Forum's 19th Annual Institutional Investor...
Quinnova Pharmaceuticals, Inc. Announces Appointment of Senior Vice President of Research & Development
NEWTOWN, Pa.-(Business Wire)-September 4, 2008 - Quinnova Pharmaceuticals, Inc. announced today the appointment of Dr. Christopher Hensby as Senior Vice President Research & Development. Dr. Hensby will assume his new post starting in October of 2008. Dr. Hensby is a graduate BSc. in...
Total Learning Concepts Introduces Training Guide for Sales Representatives New to the Biopharma Industry
LAWRENCEVILLE, N.J.-(Business Wire)-September 4, 2008 - Total Learning Concepts, a training content company that specializes in e-Learning, has introduced a new, interactive training guide—Introduction to Pharmaceutical Sales—for sales representatives who are new to the pharmaceutical...
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.-(Business Wire)-September 4, 2008 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in...
Fairway Medical Technology to Develop Biosensor for Blood Pathogens and Warfare Threats
HOUSTON-(Business Wire)-September 4, 2008 - Fairway Medical Technologies, Inc. has received a $900,000, 3-year contract from the Department of the Navy to apply its optoacoustic technology to the real-time detection of blood borne pathogens and biological warfare agents under battlefield conditions...
PerkinElmer to Present at UBS Best of Americas Conference
WALTHAM, Mass.-(Business Wire)-September 4, 2008 - PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Best of Americas Conference on Thursday, September 11, 2008, at 13.50 p.m. British Summer Time at the UBS Conference...
Abraxis and ProMetic Enter License Agreements for up to $295 M US for Four Biopharmaceuticals
LOS ANGELES & MONTREAL-(Business Wire)-September 4, 2008 - Abraxis BioScience, Inc. (NASDAQ:ABII) and ProMetic Life Sciences Inc. (TSX:PLI) announced today that they have signed definitive agreements for the development and commercialization, on a world-wide basis (excluding China and Taiwan...
Research and Markets: A Company Profile of the Sigma-Aldrich Corporation: Providing a SWOT Analysis and Detailed Company Overview
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets is a life science and high technology company engaged in providing biochemicals and organic chemicals. The company operates in 36 countries. It is headquartered in St. Louis, Missouri and employs more than 7,800 people. The...
Biogen Idec to Present at the 3rd Annual CITI Biotech Day
CAMBRIDGE, Mass.-(Business Wire)-September 4, 2008 - Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the CITI Biotech Day will be webcast live via the internet, on Monday, September 8, 2008 at 3:20 p.m. ET. To access the live webcast, please visit Biogen Idec's Investor...
Banyan Biomarkers Announces U.S. Patent for Neural Proteins as Biomarkers for Traumatic Brain Injury
ALACHUA, Fla.-(Business Wire)-September 4, 2008 - Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 "Neural Proteins as Biomarkers for Traumatic Brain Injury," licensed exclusively by Banyan Biomarkers from the University of...
Clinical Resource Network Named to 2008 Inc. 5000 List
DEERFIELD, Ill.-(Business Wire)-September 4, 2008 - Inc. announced it placed Clinical Resource Network (CRN) 2674th on its 2008 annual ranking of the 5,000 fastest-growing private companies in the country and in the Top 100 businesses in the greater Chicagoland area on August 20, 2008. The list is...
Minerva Settles Litigation
BOSTON-(Business Wire)-September 4, 2008 - Minerva Biotechnologies Corporation and James Czirr, its former Chief Executive Officer, today announced the resolution of their legal dispute. As part of the settlement, each of the parties withdrew all allegations of misconduct and the Company accepted...
Philip A. Theodore Joins BioReliance Corporation as Vice President, Compliance, Legal and Corporate Development
ROCKVILLE, Md.-(Business Wire)-September 4, 2008 - BioReliance Corporation announced today that Philip A. Theodore has been named Vice President, Compliance, Legal and Corporate Development. BioReliance Corporation is a leading contract services company that provides biologics safety testing...
Aethlon Medical Releases Shareholder Letter
SAN DIEGO-(Business Wire)-September 4, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the...
Healthnostics Meets Significant Milestones
NEW YORK-(Business Wire)-September 4, 2008 - Healthnostics, Inc. (OTC:HNSO), a medical and biotechnology information and technology company, is pleased to provide the following update on specific milestones and the company's progress to date for 2008. GMD Since our acquisition of a major interest in...
The Discovery Stage Partnering Agreements in Biopharma Report Provides Data on Deal Trends Since 2000, Over 1000 Actual Contracts and Real Case Studies
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets Subject to being published via regulatory requirements of the Securities Exchange Commission. Report Scope: Discovery Stage Partnering Agreements in Biopharma is intended to provide the reader with an in-depth understanding of...
Dow Pharmaceutical Sciences, Inc. Expands Clinical Labeling Capabilities in Petaluma, California
PETALUMA, Calif.-(Business Wire)-September 4, 2008 - Dow Pharmaceutical Sciences, Inc. recently announced expansion of its internal clinical labeling printing capabilities. With the addition of non-smear thermal transfer printers and software that allows for uploading and printing of random codes...
Janet Wolfe, President of Wolfe Laboratories, Named Boston's Entrepreneur of the Year
WATERTOWN, Mass.-(Business Wire)-September 4, 2008 - Janet Wolfe, Ph.D., President of Wolfe Laboratories, Inc. (WLI), was named Boston's Entrepreneur of the Year by the Greater Boston Chamber of Commerce. The award recognizes the achievements of small business owners and their contributions to the...
ABMC Products to Be Used by the French Ministry of Interior
KINDERHOOK, N.Y.-(Business Wire)-September 4, 2008 - American Bio Medica Corporation (NASDAQ:ABMC) announced today that they have been awarded, through their master European distributor, MAVAND Solutions GmbH, a government tender with the French Ministry of Interior. Effective immediately, the...
BIOMAX INFORMATICS AG Releases the New BioXM Version 3.0, A Major Upgrade of Its Flagship Enterprise Platform for Semantic Data Integration and Knowledge Management
MARTINSRIED, Germany-(Business Wire)-September 4, 2008 - Biomax Informatics today announced the new release of a major upgrade of its flagship product BioXM(TM) Knowledge Management Environment. The BioXM system integrates information from different data sources to dynamically build semantic...
CSMG Technologies Expands Corporate Home Office to Facilitate Company Growth
CORPUS CHRISTI, Texas-(Business Wire)-September 4, 2008 - CSMG Technologies, Inc. (OTCBB: CTGI), a technology management company, announced the company is today moving its corporate home office, expanding into larger office space in order to accommodate additional personnel, its growing core...
'HealthGate Governance(TM)' Application Addresses Mounting Requirements for Governance, Transparency and Accountability in Healthcare Quality and Improvement Initiatives
BURLINGTON, Mass.-(Business Wire)-September 4, 2008 - HealthGate Data Corp. announced today the availability of HealthGate Governance(TM), a collection of web-based tools designed specifically to help hospitals and health systems manage the complex governance issues associated with quality and...
Q Pharma, Inc. Names Bryan Koslow Vice President of Sales and Marketing
MORRISTOWN, N.J.-(Business Wire)-September 4, 2008 - Q Pharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today that Bryan Koslow has joined the firm as Vice President of Sales and Marketing. In this role, Koslow will lead the development and execution of Q...
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
FLEMINGTON, N.J.-(Business Wire)-September 4, 2008 - NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan...
Synageva BioPharma Appoints Sanj K. Patel President and Chief Executive Officer and Opens New Corporate Headquarters
WALTHAM, Mass.-(Business Wire)-September 4, 2008 - Synageva BioPharma announced today the appointment of Sanj K. Patel as President and Chief Executive Officer. Sanj joins Synageva from Genzyme Therapeutics and brings experience from one of the industry's leading biopharmaceutical producers and an...
Colorado BioScience Association Seeks Region's Top Innovators for Venture Showcase Competition at 2008 BioWest Conference & Expo
DENVER-(Business Wire)-September 4, 2008 - What do Apoplogic Pharmaceuticals, Inviragen and ValveXchange have in common? All three have been past winners of the BioWest Venture Showcase award. Rick Duke, Dan Stinchcomb and Ivan Vesely all report that winning the award provided them with local and...
Apollo Medical Holdings, Inc., Medical Management Leader, Begins Trading on the OTC-BB
GLENDALE, Calif.-(Business Wire)-September 4, 2008 - Apollo Medical Holdings, Inc. (OTCBB:AMEH), a leading provider of management services to medical groups that provide comprehensive hospital-based medical services, today announced that it completed its reverse merger with Siclone Industries...
Nanotherapeutics Files Investigational New Drug Application for NanoDOX(TM) Hydrogel to Treat Lower Extremity Diabetic Ulcers
ALACHUA, Fla.-(Business Wire)-September 4, 2008 - Nanotherapeutics, a privately held specialty biopharmaceutical company, announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX(TM) Hydrogel, a...
Gryphon Investors Recapitalizes Synteract and Vince & Associates
SAN FRANCISCO-(Business Wire)-September 4, 2008 - Gryphon Investors announced today that it led the simultaneous recapitalization of Synteract, Inc. ("Synteract") and Vince & Associates Clinical Research ("VNA") in partnership with management and Celerity Partners. Both Synteract and VNA provide...
NeoPharm Granted Additional Time to Regain Listing Compliance on NASDAQ
LAKE BLUFF, Ill.-(Business Wire)-September 4, 2008 - NeoPharm, Inc. (NASDAQ: NEOL), today announced that, on September 2, 2008, the Company received a letter from the NASDAQ Listing Qualifications Panel (the "Panel") informing the Company that the Panel had determined to grant the Company's...
Cougar Biotechnology to Present at Morgan Stanley Global Healthcare Conference
LOS ANGELES-(Business Wire)-September 4, 2008 - Cougar Biotechnology, Inc. (NASDAQ: CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, at 9:10 a.m. EDT at the...
Bio-Imaging Technologies to Present at Baird's 2008 Small Cap Health Care Conference September 10, 2008
NEWTOWN, Pa.-(Business Wire)-September 4, 2008 - Bio-Imaging Technologies, Inc. ("Bio-Imaging") (NASDAQ: BITI) today announced that its President and Chief Executive Officer, Mark L. Weinstein, is scheduled to present at Baird's 2008 Small Cap Health Care Conference at 2:10 pm (EDT) on Wednesday...
MDRNA Receives Additional Funding from National Institutes of Health
BOTHELL, Wash.-(Business Wire)-September 4, 2008 - MDRNA, Inc. (Nasdaq: MRNA) announced today that the National Institutes of Health (NIH) has awarded the Company over $350,000 for further development of the Company's siRNA therapeutics program to prevent and treat influenza. These funds are part of...
Accelr8 Announces Independent Study Presentations and New Rapid ESBL Test
DENVER-(Business Wire)-September 4, 2008 - Accelr8 Technology Corporation (Amex: AXK) announced today that the company and its research collaborators have completed two studies that characterize technical advances for its BACcel(TM) rapid diagnostic system. The system is being developed to rapidly...
FDA Assigns Priority Review to GTC Biotherapeutics' ATryn(R)
FRAMINGHAM, Mass.-(Business Wire)-September 4, 2008 - The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s ("GTC", Nasdaq: GTCB) Biologic License Application, or BLA, for ATryn(R). Priority Review is granted to applications for products that, if...
Isis Receives Notices of Allowance That Significantly Expand the Scope of Key RNA Therapeutic Patents
CAMBRIDGE, Mass. & CARLSBAD, Calif.-(Business Wire)-September 4, 2008 - Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and the companies' joint venture Regulus Therapeutics LLC, announced today that the United States Patent and Trademark Office (USPTO...
Invitrogen Launches Patent Licensing Program for Enabling Amplification Technology
CARLSBAD, Calif.-(Business Wire)-September 4, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and...
Roche NimbleGen's Revolutionary Sequence Capture Technology Now Available for Use in Research Laboratories
MADISON, Wis-(Business Wire)-September 4, 2008 - This spring, Roche NimbleGen announced the launch of their Sequence Capture Technology, a groundbreaking technique for enriching targeted genomic regions for high-throughput sequencing. Initially offered as a service, the Sequence Capture Technology...
Geron Corporation to Present at Thomas Weisel Partners Healthcare Conference
MENLO PARK, Calif.-(Business Wire)-September 4, 2008 - Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's product development programs at 9:45 am EDT on Friday, September 5, 2008, at the...
Applied Biosystems Teams With Leaders in Connecticut and New Jersey to Drive Stem Cell Research
FOSTER CITY, Calif.-(Business Wire)-September 4, 2008 - Scientists conducting stem cell research are convening at symposia in mid-September in Connecticut and New Jersey to share best practices, drive standardization to advance science, and enable greater collaboration. By teaming with Connecticut...
Pediatrix Completes New $350 Million Credit Facility
FORT LAUDERDALE, Fla.-(Business Wire)-September 4, 2008 - Pediatrix Medical Group, Inc. (NYSE:PDX) today announced that it has completed a new $350 million revolving credit facility that will provide a funding source for acquisitions, as well as other corporate purposes. The credit facility also...
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
LEXINGTON, Mass.-(Business Wire)-September 4, 2008 - EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Bayer...
Latest Advanced Minimally Invasive Surgical Techniques for Treatment of Atrial Fibrillation and Mitral Valve Disease Featured During Live Televised Procedure at EACTS Techno-College 2008 in Lisbon, Portugal on September 13, 2008
LISBON, Portugal & SAN RAMON, Calif.-(Business Wire)-September 4, 2008 - A live case demonstrating ground-breaking effective techniques for surgical treatment of Atrial Fibrillation and Mitral Valve diseases will be performed by Dr. Ralf Krakor at Stadtische Kliniken Hospital in Dortmund...
Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS
MELBOURNE, Australia-(Business Wire)-September 4, 2008 - Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons...
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
BOTHELL, Wash. & TOKYO-(Business Wire)-September 4, 2008 - Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. announced today that they have entered into a definitive agreement to co-develop Acucela's lead compound ACU-4429 which is currently in Phase I clinical development for the dry form of...
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye
BOTHELL, Wash. & TOKYO-(Business Wire)-September 4, 2008 - Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. today announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension (hereinafter, Rebamipide), Otsuka's proprietary compound for the treatment...
Directory of Top 60 Biopharmaceutical Manufacturers in India Revealed in Comprehensive Industry Review
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets - Viswagen Biotech Pvt. Ltd. - Wockhardt Biopharmaceuticals - Yashraj Biotechnology Limited - Zenotech Laboratories Limited *T For more information visit http://www.researchandmarkets.com/research/4006eb/directory_of_top_6
Natrix Separations Announces $19 Million Series B Financing
BURLINGTON, Ontario-(Business Wire)-September 3, 2008 - Natrix Separations Inc., a privately held company that develops and manufactures high performance, membrane-based disposable chromatography products, announced today that it has closed a Series B financing totaling $19 Million. The round was...
Precision Dynamics Releases New Ident-Alert(TM) Colored Snaps Providing Hospitals with Quick and Easy Patient Alert ID
SAN FERNANDO, Calif.-(Business Wire)-September 3, 2008 - Precision Dynamics Corporation (PDC), the leader of automated wristband identification, announces the release of Ident-Alert(TM) Colored Snaps. As the newest addition to PDC's Alert Band(R) ID products, Ident-Alert(TM) Colored Snaps will...
Celgene Corporation to Present at the 3rd Annual Citi Biotech Day
SUMMIT, N.J.-(Business Wire)-September 3, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 9:00 a.m. EDT will be webcast live and will be available in the investor relations section of the company's Web site...
AMRI Announces Leadership Changes in Pharmaceutical Development and Manufacturing
ALBANY, N.Y.-(Business Wire)-September 3, 2008 - AMRI (NASDAQ: AMRI) announced today that Steven R. Hagen, Ph.D. has been promoted to vice president of pharmaceutical development and manufacturing, reporting to AMRI Chairman, President and CEO Thomas E. D'Ambra, Ph.D. Previously, Dr. Hagen was...
Biodel to Report Results of VIAject(TM) Pivotal Phase III Clinical Trials at EASD Conference
DANBURY, Conn.-(Business Wire)-September 3, 2008 - Biodel Inc. (Nasdaq: BIOD) announced today that it will report results of its two pivotal Phase III clinical trials of VIAject(TM) in patients with Type 1 and Type 2 diabetes next week at the 44th Annual Meeting of the European Association for the...
Biovail Announces Filing of ANDA for Fenofibrate Tablets
TORONTO-(Business Wire)-September 3, 2008 - Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate...
International Diplomatic Contingent Visits Medtronic
MINNEAPOLIS-(Business Wire)-September 3, 2008 - This morning, more than 50 members of the Foreign Diplomatic Corps, including 36 Ambassadors from around the world, participated in a business networking event at Medtronic, Inc. (NYSE: MDT), the world's leading medical device technology company...
CardioNet, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
CONSHOHOCKEN, Pa.-(Business Wire)-September 3, 2008 - CardioNet, Inc. (NASDAQ:BEAT) announced today that Arie Cohen, President and CEO will be presenting at the Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4, 2008 at 4:25 PM, Eastern Time, at The Four Seasons Hotel...
Emergent BioSolutions Receives $24 Million Development Contract from the Department of Health and Human Services to Fund Continued Development of Anthrax Monoclonal Antibody
ROCKVILLE, Md.-(Business Wire)-September 3, 2008 - Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has received a contract from the Department of Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent's anthrax monoclonal antibody AVP-21D9...
Teva and Barr Receive FTC Request for Additional Information
JERUSALEM & MONTVALE, N.J.-(Business Wire)-September 3, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second...
Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO
REDWOOD CITY, Calif.-(Business Wire)-September 3, 2008 - Genelabs Technologies, Inc. (NASDAQ:GNLB) today announced the appointment of Frederick W. Driscoll as President and Chief Executive Officer and as a member of its Board of Directors. Genelabs is a biopharmaceutical company focused on the...
Commonwealth Biotechnologies, Inc. Reports Progress on its new Laboratories in China
RICHMOND, Va.-(Business Wire)-September 3, 2008 - Commonwealth Biotechnologies, Inc. ("CBI") (NASDAQ Capital Market: CBTE) is pleased to provide an update regarding Venturepharm (Asia), CBI's joint venture with Venturepharm Laboratories Ltd ("VPL") (HKEX: 8225.HK). The joint venture was...
PraxisDirect 2.0 Forecasts Enrollment Success
NASHVILLE, Tenn.-(Business Wire)-September 3, 2008 - Praxis, a company specializing in centralized patient recruitment for clinical research studies, is proud to announce the release of PraxisDirect 2.0, the most advanced technology in patient recruitment management. Hundreds of thousands of...
Genetix Group plc Awarded Scottish NHS Cytogenetics Contract
NEW MILTON, UK-(Business Wire)-September 3, 2008 - Genetix Group plc (AIM: GTX), the cancer diagnostic and biopharmaceutical technologies group, today announces that it has been awarded a contract to develop and implement a nationwide network of Automated Cytogenetic Analysis Systems by NHS National...
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
PARSIPPANY, N.J.-(Business Wire)-September 3, 2008 - The Medicines Company (NASDAQ:MDCO) today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in...
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
NEW YORK-(Business Wire)-September 3, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent...
Alte Biosciences Files Patent for New Inflammatory Bowel Disease Drugs
CARY, N.C.-(Business Wire)-September 3, 2008 - Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of drugs that may benefit patients with inflammatory bowel disease. This is the latest in a series of...
Research and Markets: Examine BSD Medical Corporation's Product Pipeline with New Analysis
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets has announced the addition of the "BSD Medical Corporation Product Pipeline Analysis" company profile to their offering. This report is an insightful source for data, analysis and strategic insights into a BSD Medical...
Wall Street Analyst Forum 2008 Presenter Profiles for AVANIR Pharmaceuticals and DRI Corporation
NEW YORK-(Business Wire)-September 3, 2008 - Wall Street Analyst Forum 2008 takes place September 08, 2008 - September 10, 2008 at The University Club in New York City. Listed below are the Wall Street Analyst Forum 2008 presenter profiles for Avanir Pharmaceuticals and DRI Corporation. For in-depth...
Heartbeat Digital Recognized as Google Adwords-Qualified Agency
NEW YORK-(Business Wire)-September 3, 2008 - Heartbeat Digital, an Interactive media agency based in Manhattan, has been named an official Google AdWords Qualified Company. To merit this recognition, Heartbeat was rigorously tested using Google's highly competitive Advertising Professionals exam...
Research and Markets: A Competitor Analysis Report of Toll-Like Receptor (TLR) Agonists & Antagonists
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets for TLR Agonists, Antagonists, Adjuvants and TLR-Adjuvanted Vaccines is contained in this Competitor Analysis. -0- *T The report includes a compilation of current active projects in the research and development of TLR...
XenoPort to Present at the Morgan Stanley Healthcare Conference
SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Unplugged Conference. The live presentation will occur at 8:30 a.m. Pacific Time...
Rexahn Pharmaceuticals Expands Cancer Patent Portfolio
ROCKVILLE, Md.-(Business Wire)-September 3, 2008 - Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced today that the U.S. Patent & Trademark Office has issued a new cancer patent (U.S. Patent 7,405,214...
Azaya Therapeutics Licenses Promising Treatment for Head and Neck Cancers
SAN ANTONIO-(Business Wire)-September 3, 2008 - Azaya Therapeutics, Inc., announced today that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying...
BioMedical Technology Solutions Holdings, Inc. Changes Stock Ticker Symbol From CETR to BMTL and Completes 1 for 3 Reverse Stock Split
DENVER-(Business Wire)-September 3, 2008 - BioMedical Technology Solutions Holdings, Inc. (OTCBB: BMTL) changed its ticker symbol from CETR to BMTL, reflecting the previously announced reverse merger with CET Services, Inc. In conjunction with this ticker change, the company has completed a 1 for...
Redpoint Bio to Present at the 19th Annual Wall Street Analyst Conference
EWING, N.J.-(Business Wire)-September 3, 2008 - Redpoint Bio Corporation (OTCBB: RPBC), a company leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste modulators for the food, beverage and pharmaceutical industries, today announced that Chief...
Stentys Appoints Rene Spaargaren, MD, as Chief Medical Officer
PARIS-(Business Wire)-September 3, 2008 - Stentys the balloon inflation disconnects the mesh and creates the opening—Stentys' self-expanding property allows the in situ modeling of the stent to fit the patient's unique arterial anatomy. About Stentys Based in Paris, Stentys intends to make...
Scientists Who Linked HPV with Cervical Cancer Win 20th Annual Warren Alpert Foundation Prize
BOSTON-(Business Wire)-September 3, 2008 - Two scientists who discovered that specific types of human papillomavirus, or HPV, cause cancer of the cervix were announced today as winners of the 20th annual Warren Alpert Foundation Scientific Prize. The Foundation recognizes Harald zur Hausen...
ViroPharma and Lev Receive Hart-Scott-Rodino Clearance from the Federal Trade Commission
EXTON, Pa.-(Business Wire)-September 3, 2008 - ViroPharma Incorporated (Nasdaq: VPHM) and Lev Pharmaceuticals, Inc. (OTCBB: LEVP) today announced that the waiting period required under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act has expired in connection with ViroPharma's proposed...
Bristol-Myers Squibb and AstraZeneca to Hold Investor Teleconference to Discuss EASD Highlights
NEW YORK-(Business Wire)-September 3, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) will host a conference call at 9 a.m. (ET) on Tuesday, September 9 to review data presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD), being...
BioImagene Appoints Prominent Pathologist Dr. Robert J. Monroe as Chief Medical Officer
CUPERTINO, Calif.-(Business Wire)-September 3, 2008 - BioImagene, the leader in providing innovative and affordable digital pathology solutions for cancer diagnosis and research, strengthened its executive team with the appointment of Robert J. Monroe, M.D., Ph.D., as Chief Medical Officer (CMO...
New Data on the Benefit of Cardiac Devices in Heart Failure Patients Presented At ESC Congress 2008
MINNEAPOLIS & MUNICH, Germany-(Business Wire)-September 3, 2008 - New analyses presented today during the annual congress of the European Society of Cardiology (ESC) on the effects of cardiac resynchronisation therapy (CRT) in patients with mild heart failure from the REVERSE...
Plexxikon Initiates Phase 1 Trial for PLX5568
BERKELEY, Calif.-(Business Wire)-September 3, 2008 - Plexxikon Inc. today announced that it has initiated a Phase 1 human clinical trial for PLX5568, a novel kinase inhibitor targeted for the treatment of at least two major indications with unmet medical needs: pain as well as polycystic kidney...
Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market
BILLERICA, Mass. & SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - Millipore Corporation (NYSE: MIL) and Agilent Technologies Inc. (NYSE: A) today announced they have formed a collaboration to develop innovative ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics...
Aeris Therapeutics Announces Phase 2 Trial Results for Non-Surgical Emphysema Treatment
WOBURN, Mass.-(Business Wire)-September 3, 2008 - Aeris Therapeutics, Inc. (www.aerist.com), a company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases, today announced that the primary efficacy endpoint in Phase 2...
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
FORT LEE, N.J.-(Business Wire)-September 3, 2008 - Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, and Aegera Therapeutics, a private clinical stage company focused on oncology and neuropathic...
Brian Hare Joins PBE as Senior VP--New Business Acquisition
PRINCETON, N.J.-(Business Wire)-September 3, 2008 - Princeton Brand Econometrics (PBE) announced today that Brian M. Hare, former Senior Product Manager for Solvay Pharmaceuticals Inc, has joined the Company as Senior Vice President-Director New Business Acquisition & Development. "Brian has a...
Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation
SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - Affymetrix Inc. (Nasdaq:AFFX) today announced the launch of its 3' IVT Express Kit, a faster and more reliable option for manual target preparation on Affymetrix' industry-standard 3' IVT array cartridges. The kit offers new streamlined...
57 Start-Up Device Companies Confirmed to Present at Medtech Insight/Windhover Information's "Investment In Innovation (In3) East" Conference
IRVINE, Calif.-(Business Wire)-September 3, 2008 - Medtech Insight, a division of FDC-Windhover, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that 57 early- to late-stage companies are now confirmed to present at their upcoming...
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
CAMBRIDGE, Mass. $ CARLSBAD, Calif.-(Business Wire)-September 3, 2008 - Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced...
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
EAST HILLS, N.Y.-(Business Wire)-September 3, 2008 - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, announced today the purchase of GeneSystems, a privately held French biotechnology company that has developed a unique, easy-to-use and cost-effective...
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821
MELVILLE, N.Y.-(Business Wire)-September 3, 2008 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes...
Celgene Corporation to Present at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008
SUMMIT, N.J.-(Business Wire)-September 3, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008 on Friday, September 5, 2008 at 9:10 a.m. EDT will be webcast live and will be available in the investor...
Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program
THE WOODLANDS, Texas-(Business Wire)-September 3, 2008 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced the establishment of a...
ProtoKinetix Contracted to Produce AAGP(TM) for New Product Launch
VANCOUVER-(Business Wire)-September 3, 2008 - ProtoKinetix Inc. (OTCBB:PKTX) is pleased to announce their first commercial contract to manufacture and provide AAGP(TM) as the key active ingredient in a topical anti-inflammatory cream. This new product is expected to be launched within the next few...
Applied Biosystems to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference on September 9
FOSTER CITY, Calif.-(Business Wire)-September 3, 2008 - Applied Biosystems Inc. (NYSE:ABI) announced today that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9. Dennis Winger, Chief Financial Officer, will provide a brief opening statement...
LUNESTA(R) Next-Day Function and Discontinuation Data from a Long-Term 12-Week Study in Elderly Patients Presented at ECNP
MARLBOROUGH, Mass.-(Business Wire)-September 3, 2008 - Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of LUNESTA(R) brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona. The poster presentations reflected results...
Phase III U.S. Pivotal Study Results on CSL Biotherapies' Afluria(R) Published in Vaccine
KING OF PRUSSIA, Pa.-(Business Wire)-September 3, 2008 - Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria(R) elicited an immune response (also known as immunogenicity) in healthy adults aged 18 - less than 65...
Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases
NEW YORK & SAN FRANCISCO-(Business Wire)-September 3, 2008 - Pfizer Inc (NYSE: PFE) and Medivation, Inc.(NASDAQ: MDVN) announced today that they have entered into an agreement to develop and commercialize Dimebon, Medivation's investigational drug for treatment of Alzheimer's disease and...
Hadasit's Double Lumen PCI Guiding Catheter Prototype Demonstrates to be the First Guiding Catheter to Successfully Enable Administration of Medicine Directly to the Coronary Artery Throughout the Course of a PCI
EIN KEREM, Israel-(Business Wire)-September 3, 2008 - Hadasit, the technology transfer company of Hadassah Medical Organization, announced today the successful pre-clinical testing of a prototype of the Double Lumen PCI Guiding Catheter for use in the treatment of coronary artery disease. Unlike...
Antares Pharma Enters Into a Feasibility Development Agreement with Dr. Reddy's Laboratories, Inc. for an Enhanced Dermatology Product Utilizing the ATD Gel Platform
EWING, N.J.-(Business Wire)-September 3, 2008 - Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, today announced that they have entered into a development agreement with Dr. Reddy's Laboratories, Inc...
Clinical Data Receives Lilly Global Supplier Award
NEWTON, Mass.-(Business Wire)-September 3, 2008 - Clinical Data, Inc. (NASDAQ:CLDA) announced today that its Cogenics(R) division, the global leader in outsourced genomics services, has been recognized by Eli Lilly and Company for offering value-based genomics solutions that enable Lilly to create...
Clarient to Present at the Baird Small Cap Health Care Conference on September 10
ALISO VIEJO, Calif.-(Business Wire)-September 3, 2008 - Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced that its Vice Chairman and CEO Ron Andrews is scheduled to...
Regeneron's ARCALYST(R) (rilonacept) Reduced Incidence of Gout Flares by 81 Percent in a Phase 2 Study in Gout Patients Initiating Urate-Lowering Therapy
TARRYTOWN, N.Y.-(Business Wire)-September 3, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that treatment with ARCALYST(R) (rilonacept), also known as IL-1 Trap, in a Phase 2 study of gout patients initiating therapy with allopurinol to lower their uric acid levels...
Natus Medical to Acquire NeuroCom International
SAN CARLOS, Calif.-(Business Wire)-September 3, 2008 - Natus Medical Incorporated (Nasdaq:BABY) today announced that it has agreed to acquire privately held NeuroCom International, Inc. NeuroCom, based in Clackamas, Oregon, develops and markets computerized systems for the assessment and...
Surgical, Healthcare, Assistive, and Campus Robot Market Strategy, Market Shares, and Market Forecasts, 2008-2014
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets . The iRobot ConnectR is a way to stay connected to family and friends even when apart. ConnectR is used in pilot programs initially. ConnectR robots are available directly from iRobot as part of a pilot program. ConnectR Pilot...
Quotient Bioscience Receives Strategic Investment of GBP 35 Million from TA Associates
NEWMARKET, United Kingdom-(Business Wire)-September 3, 2008 - Quotient Bioscience Group Limited ("Quotient" or "the Company"), a leading provider of analytical and safety evaluation services and products for bioscience and sport, today announced it has raised a significant minority investment of...
Alpha Innotech and GE Healthcare Announce a Strategic Alliance Partnership
SAN LEANDRO, Calif.-(Business Wire)-September 3, 2008 - Alpha Innotech Corp. (OTCBB:APNO) today announced that it has entered into a five year Strategic Supplier Alliance Agreement with GE Healthcare (NYSE:GE). This agreement is a continuation and expansion of the previous OEM Agreement signed...
Hotel-Dieu Grace First Hospital in Canada to Adopt Autopulse
CHELMSFORD, Mass.-(Business Wire)-September 2, 2008 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that Hotel-Dieu Grace Hospital (HDGH) in Windsor, Ontario is the first hospital in Canada to have installed the...
Dr. Evan Manolis Appointed Chairman of the Board for Acrongenomics, Inc.
GENEVA-(Business Wire)-September 2, 2008 - Acrongenomics Inc. (OTCBB: AGNM) today announces that Dr. Evan Manolis is appointed Chairman of its Board of Directors effective immediately. Dr. Manolis has been a board member of Acrongenomics since 2006. He received his B.Sc. from University of...
Regeneron Announces Webcast Presentation of Results from Phase 2 Study of ARCALYST(R) (rilonacept) in Gout Patients Initiating Urate-Lowering Therapy
TARRYTOWN, N.Y.-(Business Wire)-September 2, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Dr. Leonard S. Schleifer, President and Chief Executive Officer of Regeneron, and other members of senior management will host a webcast conference call commencing at 8:30 a.m...
Cell Genesys to Present at the NewsMakers in the Biotech Industry Conference
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 2, 2008 - Cell Genesys, Inc. (Nasdaq:CEGE) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update at the NewsMakers in the Biotech Industry Conference in New York...
Merriman Curhan Ford Hires Veteran Biotechnology Analyst Edward H. Nash
SAN FRANCISCO-(Business Wire)-September 2, 2008 - Merriman Curhan Ford Group, Inc. (NASDAQ:MERR) today announced that it has hired Edward H. Nash as a senior biotechnology equity research analyst and managing director. Nash will be based out of the New York office. "Edward brings a high level of...
Celgene Corporation to Present at the NewsMakers in the Biotech Industry Conference
SUMMIT, N.J.-(Business Wire)-September 2, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008 at 2:00 p.m. EDT will be webcast live and will be available in the investor relations section of...
Sucampo Pharmaceuticals Limited Appoints New Head of Business Development
BETHESDA, MD-(Business Wire)-September 2, 2008 - Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced the appointment of Masanori Ueda as Senior Vice President, Business Development at Sucampo Pharma, Ltd., Chiyoda-ku, Tokyo, Japan, a wholly-owned subsidiary, effective September 1, 2008...
Cougar Biotechnology to Present at Citi Biotech Day
LOS ANGELES-(Business Wire)-September 2, 2008 - Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the 3rd Annual Citi Biotech Day on Monday, September 8, at 11:15 a.m. EDT at the Citi Executive...
Somaxon Presents Pharmacological Data on Doxepin at the 21st European College of Neuropsychopharmacology Congress
SAN DIEGO-(Business Wire)-September 2, 2008 - Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology, today...
Alkermes' Corporate Presentation to be Webcast at Two Upcoming Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Tuesday, September 9, 2008 at 9:45 a.m. EDT and by Robert W. Baird on Wednesday, September 10, 2008 at 12:40 p.m. EDT. The...
Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca Biosciences
CONCORD, Ohio-(Business Wire)-September 2, 2008 - Ricerca Biosciences, a uniquely integrated preclinical provider of contract research services for the pharmaceutical industry has named Gary Jacobson executive vice president and chief financial officer. In addition to his financial responsibilities...
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
WARREN, N.J.-(Business Wire)-September 2, 2008 - Cordis Corporation today announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral...
Orthofix International Announces First Annual Investor Day
BOSTON-(Business Wire)-September 2, 2008 - Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that it will hold its First Annual Investor Day on Monday, September 8th at Le Parker Meridien in New York City. The event will begin at 8:30 AM Eastern Time with a display of key...
Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference
BOULDER, Colo.-(Business Wire)-September 2, 2008 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 and the Baird Small Cap Healthcare Conference on September...
IVAX Diagnostics Reports Sale of Parent Company's Interest
MIAMI-(Business Wire)-September 2, 2008 - IVAX Diagnostics, Inc. (AMEX:IVD) announced that today a group controlled by two experienced and well-known international medical diagnostics and pharmaceutical industry entrepreneurs, Paul Kennedy and Patrice Debregeas, purchased from Teva Pharmaceutical...
Families and Organizations Invited to Give BIG for Children in Need
PHILADELPHIA-(Business Wire)-September 2, 2008 - Individuals, families and organizations throughout the Philadelphia region are invited to help needy children this fall through Shire's "BIG GIVE" event benefiting Cradles to Crayons, a non-profit that helps children. The goal: to collect donated...
The Global Biotech Industry Monitor Gives a Comprehensive Analysis of the Global Biotech Market
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets has announced the addition of the "Global Biotech Industry Monitor" report to their offering. The Global Biotech Industry Monitor gives a summary and analysis of the global biotech market including mergers acquisitions...
Synovis Life Technologies to Present at the Seventh Annual Sidoti & Company West Coast Institutional Investor Forum on Monday, September 8
ST. PAUL, Minn.-(Business Wire)-September 2, 2008 - Synovis Life Technologies, Inc. (NASDAQ: SYNO), a diversified medical device company, will present at the Seventh Annual Sidoti & Company West Coast Institutional Investor Forum on Monday, Sept. 8, 2008, at 8:30 a.m. PT (10:30 a.m. CT; 11:30...
Bridge Laboratories' China Study Data Accepted by the FDA
GAITHERSBURG, Md.-(Business Wire)-September 2, 2008 - Bridge Laboratories announced today that the FDA has accepted data submitted from its Beijing facility on behalf of a US biotech client. The Good Laboratory Practices (GLP) nonhuman primate toxicology study data was generated and submitted last...
Biotech Drops Back to Earth in August, Burrill Finds
SAN FRANCISCO-(Business Wire)-September 2, 2008 - While the general markets managed to end August in positive territory as oil continued a sharp slide, biotech came back to earth after its stellar performance in July closing in negative territory. The Dow finished up 1.5%, the NASDAQ closed the...
Use of Electronic Health Records by Eye M.D.s; Two Studies Refine Risks and Predictors for Advanced Macular Degeneration
SAN FRANCISCO-(Business Wire)-September 2, 2008 - Doctors and medical centers across the United States are debating the use of electronic health records (EHR). This month's Ophthalmology, the journal of the American Academy of Ophthalmology, provides a look at Eye M.D.s' actions and opinions on...
Registration Now Open for the Seventh Annual BIO Investor Forum
WASHINGTON-(Business Wire)-September 2, 2008 - BIO announced today that media, investor and general registration is now available for the seventh annual BIO Investor Forum that will take place October 29-31, 2008 at the Palace Hotel in San Francisco, Calif. The BIO Investor Forum is a national...
BioMedEcon Reports Six Times Higher Psychiatric Medication Costs among Patients with Obsessive-Compulsive Disorder Compared to Patients with Depression
MOSS BEACH, Calif.-(Business Wire)-September 2, 2008 - BioMedEcon Group, a leading provider of health economics and outcomes research, presented findings of a unique nine-year retrospective claims analysis that compared the per-patient, median healthcare costs of newly-diagnosed patients with...
NIH Funds Discovery of New Influenza Inhibitors by Integral Molecular, Inc.
PHILADELPHIA-(Business Wire)-September 2, 2008 - Integral Molecular, Inc. initiates a federally-funded program to discover new drugs to combat influenza infection. Sponsored by the National Institute of Allergy and Infectious Diseases, Integral Molecular's R&D program will utilize its proprietary...
CORRECTING and REPLACING Presentations on the Mechanism of Action of VEGFb(TM), the World's only "Triple Action Angiogenesis Modulator," Support VEGFb's Role as a Promising Treatment for Solid Cancers, Macular Degeneration, and Other Diseases
SUMMIT, N.J.-(Business Wire)-September 2, 2008 - Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: PRESENTATIONS ON THE MECHANISM OF ACTION OF VEGFB(TM), THE WORLD'S ONLY "TRIPLE ACTION ANGIOGENESIS MODULATOR," SUPPORT VEGFB'S...
The Global Health IT Report Gives a Comprehensive Analysis of the Global Health IT Industry Landscape
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets , another leading IT services company, announced a separate industry vertical to focus exclusively on healthcare. Meanwhile, Perot Systems grabbed a $1 billion, 13-year mega IT and business process services contract from health...
Experience Biotechnology Firsthand: BioTech4U - BIOTECHNICA 2008 Program for Schoolchildren
HANNOVER, Germany-(Business Wire)-September 2, 2008 - "BioTech4U" is the new accompanying program for schoolchildren at Europe's largest biotechnology trade fair BIOTECHNICA held from October 7 through 9, 2008. The youth initiative will be aimed at 12th-grade pupils who are particularly interested...
New Reporting from IntrinsiQ Measures Impact of Key Events on Oncology Drug Usage
WALTHAM, Mass.-(Business Wire)-September 2, 2008 - IntrinsiQ, LLC, the expert source for clinical oncology insight, today launched Event IntelliView, a new analysis tool that quantifies the real-world impact of key events in the lifecycle of medical oncology drugs. Pharmaceutical research teams...
Bayer USA Foundation Announces $100,000 Donation to The Wellness Community
PITTSBURGH-(Business Wire)-September 2, 2008 - The Bayer USA Foundation announced today that it has made a $100,000 donation to The Wellness Community (TWC), headquartered in Washington, D.C., in support of the launch of The Wellness Community's Cancer Survivorship Research & Training Institute...
AirInSpace appoints Thierry Peillon as Vice President, International Healthcare Business
WASHINGTON & PARIS-(Business Wire)-September 2, 2008 - AirInSpace, the leading supplier of mobile devices with HEPA-MD(TM) technology that 'catch and inactivate' harmful and resistant biological particles from the air, announced today that Thierry Peillon has been appointed as Vice President...
CSMG Technologies Subsidiary Live Tissue Connect Awarded European Union CE Mark Certificate; Follows Recent U.S. FDA Clearance
CORPUS CHRISTI, Texas-(Business Wire)-September 2, 2008 - CSMG Technologies (OTCBB: CTGI), a technology management company, announced its subsidiary, Live Tissue Connect Technologies (LTC), has been awarded CE Mark (Conformite Europeene) certification for its Bipolar Forceps by BSI Product...
Burnham Awarded $97.9 Million NIH Grant to Expand Small-Molecule Screening and Discovery Center
LA JOLLA, Calif.-(Business Wire)-September 2, 2008 - Burnham Institute for Medical Research (Burnham) announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH...
miRagen Therapeutics, Inc. and Collaborators Publish Study Identifying microRNA Perturbations Following Acute Myocardial Infarction
BOULDER, Colo.-(Business Wire)-September 2, 2008 - miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced the publication of novel research...
BIO-Europe 2008: The World's Leading Biotech Companies and Deal-Makers Get Ready for Three Days of Intense Partnering in Mannheim/Heidelberg
CARLSBAD, Calif. & WASHINGTON-(Business Wire)-September 2, 2008 - The leaders of the biotechnology industry will once again gather for BIO-Europe, the world's largest stand-alone partnering conference, in Mannheim/Heidelberg, Germany, November 17-19. With biotech deal-making still the thrill...
Abiomed to Present at Morgan Stanley Global Healthcare Unplugged Conference
DANVERS, Mass.-(Business Wire)-September 2, 2008 - Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008 at 9:45 a.m. ET. The conference...
LifeScience Alley(TM) Conference & Expo Showcase to Highlight Innovative New Technologies
MINNEAPOLIS-(Business Wire)-September 2, 2008 - LifeScience Alley(TM) announced today that seven life science organizations from around the Upper Midwest will be exhibiting novel technologies at the association's Annual Conference on December 10 as part of the New Technology Showcase. Three of these...
Invitrogen and Cytovance(R) Biologics Collaborate to Develop New Bioreactor Manufacturing Process of Invitrogen's New CD OptiCHO(TM) Media Platform
OKLAHOMA CITY-(Business Wire)-September 2, 2008 - Cytovance(R) Biologics LLC, a biopharmaceutical contract manufacturing company specializing in mammalian cell culture, today announced the completion of a collaboration with Invitrogen's PD-Direct(R) Bioprocess Services. Cytovance Biologics has...
BioRN Cluster Management GmbH: Biotechnology Cluster Rhine-Neckar Wins German Top Cluster Contest
HEIDELBERG, Germany-(Business Wire)-September 2, 2008 - BioRN Cluster Management GmbH today announced the success of the Rhine-Neckar biotechnology cluster (BioRN) in the Top Cluster Contest of the German Federal Ministry for Education and Research. The BioRN cluster was distinguished as one of...
Idera Pharmaceuticals Announces Milestone Payment Under Asthma and Allergy Collaboration
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will receive a milestone payment from Novartis under the two companies' research collaboration and license agreements. Under the terms of the agreement, the payment was...
Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day
WESTMINSTER, Colo.-(Business Wire)-September 2, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company's senior management will...
Optimer Pharmaceuticals Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial
SAN DIEGO-(Business Wire)-September 2, 2008 - Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) today announced that the company has completed enrollment in the second of two planned phase 3 clinical trials evaluating the safety and efficacy of Prulifloxacin for the treatment of infectious diarrhea in...
Targanta Therapeutics Announces Positive Top-Line Results from Oritavancin Phase 2 SIMPLIFI Trial
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced positive top-line results from a Phase 2 clinical trial investigating the efficacy and safety of oritavancin at Single or Infrequent Doses for the Treatment of Complicated Skin and...
Cubist Pharmaceuticals to Host Investor Event: Act 2 - Raising the Curtain on Cubist's Pipeline
LEXINGTON, Mass.-(Business Wire)-September 2, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will host an invitation-only Investor Event at the Back Bay Events Center in Boston at 4:30 P.M. ET on Monday, September 8th, 2008. The presentations will focus on the...
AtheroGenics Noteholders Expect Company Will Elect Not to Pay 2008 Notes When Due
ATLANTA-(Business Wire)-September 2, 2008 - CNH Partners, LLC, Tamalpais Asset Management LP, Tang Capital Partners, LP, and Zazove Associates LLC (the "08 Noteholders"), which collectively hold approximately 96% of the outstanding 4 1/2 % Convertible Notes Due 2008 (the "08 Notes") issued by...
New Leaf Venture Partners Expands Leadership Team, Naming Liam Ratcliffe, M.D., Ph.D., as Venture Partner
NEW YORK-(Business Wire)-September 2, 2008 - New Leaf Venture Partners (NLV Partners) announced today the appointment of Liam Ratcliffe, M.D., Ph.D., as venture partner. Dr. Ratcliffe recently served as Senior Vice President and Global Head of Clinical Research and Development for Pfizer. Dr...
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
AUSTIN, Texas-(Business Wire)-September 2, 2008 - Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, today announced that the United States Food and Drug Administration (FDA) notified the Company that its Biologics License Application (BLA) for...
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
MANSFIELD, Mass.-(Business Wire)-September 2, 2008 - Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has reached an agreement with Purdue Pharma L.P. to end a patent infringement lawsuit between them. In...
Acorda Therapeutics to Present at the 3rd Annual Citi Biotech Day Conference
HAWTHORNE, N.Y.-(Business Wire)-September 2, 2008 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present a corporate overview at the upcoming 3rd Annual Citi Biotech Day Conference on Monday, September 08, 2008 at 9:45 a.m. ET at the Citi...
Zhu Shen of BioForesight Joins Editorial Advisory Board of PharmAsia News
SAN DIEGO-(Business Wire)-September 2, 2008 - Zhu Shen, Ph.D., MBA, chief executive officer of BioForesight, a leading global life science consulting firm focusing on cross-Pacific partnering, financing advisory, and public relations and media strategy, has joined the editorial advisory board of...
Celera to Webcast Its Analyst and Investor Meeting on September 9, 2008
ALAMEDA, Calif.-(Business Wire)-September 2, 2008 - Celera Corporation (NASDAQ:CRA), announced today that it will webcast its Analyst & Investor Meeting in New York, NY, on Tuesday, September 9, 2008. The live webcast is scheduled to begin at 8:30 a.m. Eastern Time. At the meeting, Celera's...
Aethlon Medical To Present at 2008 Southern California Investor Conference
SAN DIEGO-(Business Wire)-September 2, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) today announced that Chairman and Chief Executive Officer, James A. Joyce, will present a company overview at the California Stock Report's 2008 Southern California Investor Conference being held tomorrow, September...
Fibrex Medical Report Positive Phase II Results for FX06
CAMBRIDGE, Mass. & VIENNA, Austria-(Business Wire)-September 2, 2008 - Fibrex Medical, a biopharmaceutical company focusing on cardiovascular and inflammatory diseases, today announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart...
ZymoGenetics to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
SEATTLE-(Business Wire)-September 2, 2008 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an update on company activities at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday...
ZymoGenetics Earns Milestone Payment for RECOTHROM(R) European Filing
SEATTLE-(Business Wire)-September 2, 2008 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that it will receive a $5 million milestone payment from Bayer HealthCare, which was triggered by the submission of the Marketing Authorization Application to the European Medicines Agency (EMEA) for...
BIOTECHNICA: The Role of White Biotechnology in Industrial Production
HANNOVER, Germany-(Business Wire)-September 2, 2008 - Although white or industrial biotechnology has been around for a considerable time, it has only recently begun to revolutionize industrial production. Nature's toolset is being increasingly deployed in processes that help cut production costs...
Sequenom to Present at September Investment Conferences and to Hold Analyst and Investor Briefing Event
SAN DIEGO-(Business Wire)-September 2, 2008 - Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced the Company will present at three investment conferences and will hold an analyst day event in September. The presentations are as follows: — Thomas...
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
NEW YORK & PETACH TIKVAH, Israel-(Business Wire)-September 2, 2008 - Brainstorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that world renowned ALS medical expert, Dr. Robert H. Brown, Jr., MD, PhD from Harvard...
BIOTRONIK Forges Ahead Toward Medtech Leadership Position
MUNICH, Germany-(Business Wire)-September 1, 2008 - BIOTRONIK reports a business update that indicates the company is moving on a leadership track. With a company philosophy based on "excellence for life", it is no surprise that recent years have seen BIOTRONIK achieve several best-in-class...
Bruker AXS Announces Closing of S.I.S. Acquisition and Exhibits its New Atomic Force Microscopy (AFM) Product Line at EMC 2008
AACHEN, Germany-(Business Wire)-September 1, 2008 - Bruker AXS GmbH announces the closing of its acquisition of S.I.S. Surface Imaging Systems GmbH, located near Aachen, Germany. S.I.S. develops, manufactures and distributes advanced atomic force/scanning probe microscopy (AFM/SPM) systems for...
New Approach, Old Drug Show Promise Against Hepatitis C, Stanford Research Shows
STANFORD, Calif.-(Business Wire)-August 31, 2008 - The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure...
Initial Data Presented on World's First Pacemaker Designed for Safe Use in MRI Machines
MINNEAPOLIS & MUNICH, Germany-(Business Wire)-August 31, 2008 - Initial safety and efficacy data, presented today at the European Society of Cardiology Congress, on the Medtronic, Inc. (NYSE:MDT) investigational EnRhythm MRI(TM) SureScan(TM) Pacing System show promise for a potential solution...
Toshinari Tamura, Ph.D., Joins Board of Directors of FibroGen, Inc.
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-August 29, 2008 - FibroGen, Inc. today announced that Toshinari Tamura, Ph.D., recently retired Representative Director, Executive Vice President and Chief Science Officer of Astellas Pharma, Inc., has joined FibroGen's Board of Directors. Dr. Tamura has...
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
NEW YORK-(Business Wire)-August 29, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL) today announced overall survival results from BMS CA225-099 (BMS-099), an open-label Phase 3 study of ERBITUX(R) (cetuximab) in combination with a taxane and carboplatin in the first-line treatment of all...
Cubist Pharmaceuticals to Present at September Investor Conferences
LEXINGTON, Mass.-(Business Wire)-August 29, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert Perez, EVP and COO, will present on Thursday, September 4th at 2:40 P.M. EDT, at the Thomas Weisel Partners Healthcare Conference being held at the Four Seasons Hotel in Boston...
Major Announcement About the Broad Institute Thursday, Sept. 4, 9:15am - Noon ET
-(Business Wire)-August 29, 2008 - The Broad Institute of Harvard and MIT -0- *T What: Major announcement about the future of the Broad Institute of MIT and Harvard, followed by media availability and teleconference Who: Governor Deval Patrick Governor of the Commonwealth of Massachusetts (Note...
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Thomas Weisel Partners Healthcare Conference 2008
CAMBRIDGE, Mass.-(Business Wire)-August 29, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Thomas Weisel Partners Healthcare Conference 2008 on Wednesday, September 3, 2008 at 8:00 a.m. EDT. The presentation will be...
Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before November 2011
NEW YORK-(Business Wire)-August 29, 2008 - Pfizer Inc said today that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company's favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor. The basic (DK 171,588) and enantiomer...
Affymetrix to Webcast Presentations at Two September Financial Conferences
SANTA CLARA, Calif.-(Business Wire)-August 29, 2008 - Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide a corporate overview at two upcoming financial conferences. John Batty, Executive Vice President and CFO, will present at the Thomas Weisel Partners Healthcare...
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
CAMBRIDGE, Mass.-(Business Wire)-August 29, 2008 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m. EDT. The presentation will be webcast from the Four Seasons Hotel in Boston...
ARYx Therapeutics Appoints Amgen Executive to Board of Directors
FREMONT, Calif.-(Business Wire)-August 29, 2008 - ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced the appointment of David Beier to its board of directors. Mr. Beier is a veteran of the biotechnology industry and has been instrumental in the development of United States public policy impacting...
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biotech Industry Conference
SAN DIEGO-(Business Wire)-August 29, 2008 - Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard Pascoe, the company's recently named president and chief executive officer, will present a company update at the Thomas Weisel 2008 Healthcare Conference on Thursday, September 4...
CORRECTING and REPLACING Exelixis Announces September 4 Webcast of Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-August 28, 2008 - First graph, second sentence of release should read: Mr. Karbe will discuss updates to the company's development pipeline and corporate strategy (sted Dr. Scangos will discuss...) The corrected release reads: EXELIXIS ANNOUNCES...
REVISED AND INTERNATIONAL ANNOUNCEMENT: InfrAegis Announced Again Today That It is Selling 30% of Bacteria Sciences Worldwide, LLC, an InfrAegis Company, to DLM Capital Investors for $1 Billion USD
CHICAGO-(Business Wire)-August 28, 2008 - InfrAegis announced today on behalf of Bacteria Sciences Worldwide, LLC (BSW) that DLM Capital Investors, LLC (DLM) is investing $1 billion in BSW for 30% of the Company. DLM will receive one BSW board seat. With respect to the press release of InfrAegis...
CIRM Applauds the Reprogramming of Pancreas Cells to Produce Insulin Saying It Points to the Value in Pursuing All Research Paths in Regenerative Medicine
SAN FRANCISCO-(Business Wire)-August 28, 2008 - The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, issued the following statement regarding the research published today in Nature by a team from Harvard that showed it is possible to take a type of adult pancreas...
Osiris Therapeutics to Present at Thomas Weisel Partners Healthcare Conference
COLUMBIA, Md.-(Business Wire)-August 28, 2008 - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that C. Randal Mills...
Robert Lifton, Chairman and CEO of Medis Technologies, to Be Interviewed on Corporate Strategies with Tim Connolly on Friday Morning, 6:30 Pacific Time and 9:30 Eastern Time, on CRN Radio
LAS VEGAS-(Business Wire)-August 28, 2008 - Robert Lifton, Chairman and CEO of Medis Technologies (Nasdaq: MDTL), may be heard nationwide on 400 affiliate stations nationwide listed at "CRN1" www.cableradioinetwork.com or on the Internet at www.corporate-strategies.net. Medis Technologies' primary...
Affymax to Hold Conference Call and Webcast to Provide Clinical Development Update at 5:00 P.M. Eastern Time
PALO ALTO, Calif.-(Business Wire)-August 28, 2008 - Affymax, Inc. (Nasdaq:AFFY) today announced that Affymax management will host a conference call and webcast at 5:00 p.m. Eastern Time today. The call will discuss the joint Affymax and Takeda decision to focus all development efforts for...
BioSphere Medical to Present at the Wall Street Analyst Forum Conference
ROCKLAND, Mass.-(Business Wire)-August 28, 2008 - BioSphere Medical, Inc. (NASDAQ:BSMD) ("BioSphere") - a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive...
